Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Novartis reported $112.24B in Assets for its fiscal quarter ending in March of 2023.

Assets Change
Amgen AMGN:US USD 88.72B 23.6B
AstraZeneca AZN:LN USD 96.69B 204M
Bausch Health Companies Inc VRX:CN USD 25.44B 241M
Biogen BIIB:US USD 24.6B 44.3M
Catalent CTLT:US USD 11.15B 942M
Corcept Therapeutics CORT:US USD 617.85M 34.42M
Drreddys Laboratories RDY:US INR 321.85B 12.55B
Eli Lilly LLY:US USD 53.16B 3.67B
Endo International ENDP:US USD 5.57B 191.83M
Gilead Sciences GILD:US USD 61.88B 1.3B
GlaxoSmithKline GSK:LN GBP 58.6B 1.55B
Glaxosmithkline GSK:US GBP 58.6B 1.55B
Horizon Pharma HZNP:US USD 8.99B 121.17M
J&J JNJ:US USD 195.97B 8.59B
Novartis NOVN:VX USD 112.24B 5.21B
Pacira PCRX:US USD 1.52B 157.78M
Perrigo PRGO:US USD 10.95B 62.4M
Phibro Animal Health PAHC:US USD 965.43M 3.6M
Prestige Brands PBH:US USD 3.35B 396.04M
Roche Holding ROG:VX CHF 88.15B 1.42B
Supernus Pharmaceuticals SUPN:US USD 1.79B 89.3M
Zoetis ZTS:US USD 13.75B 1.17B